(Total Views: 230)
Posted On: 10/09/2017 7:43:56 PM
Post# of 72446
Article - Capitalizing on a mutant p53 gene to fight pancreatic cancer
"The p53 gene has long held interest in the oncology research community because of its proven role as producer of a tumor-suppressing protein. But harnessing the power of p53 in the treatment of cancer has been challenging. Several mutations of the p53 gene are known, and more than 1,000 other genes are affected by p53 status, making the path to tumor suppression difficult to define."
http://www.fiercebiotech.com/research/capital...tic-cancer
"The p53 gene has long held interest in the oncology research community because of its proven role as producer of a tumor-suppressing protein. But harnessing the power of p53 in the treatment of cancer has been challenging. Several mutations of the p53 gene are known, and more than 1,000 other genes are affected by p53 status, making the path to tumor suppression difficult to define."
http://www.fiercebiotech.com/research/capital...tic-cancer
(2)
(0)
